2,4(1H,3H)-Pyrimidinedione, 6-((3-(4-(2-methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl-
ICMGLRUYEQNHPF-UHFFFAOYSA-N
6-((3-(4-(2-Methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
KBioSS_001840
6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethyl-pyrimidine-2,4-dione
MLS003115907
A78GF17HJS
NCGC00016066-07
AC1L1KST
NCGC00025290-03
BCP02494
Prestwick0_000905
BSPBio_000750
SCHEMBL48992
CHEBI:32278
Spectrum4_000233
Uracil, 1,3-dimethyl-6-(3-(4-(o-methoxyphenyl)-1-piperazinyl)propylamino)-
Urapidilum
STL454353
DSSTox_GSID_21425
Gene therapy (rheumatoid arthritis), Targeted Genetics
2,4(1H,3H)-Pyrimidinedione,6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-
KBio2_001840
6-(3-(4-(2-methoxyphenyl)piperazin-1-yl)
L005359
6-[3-[4-(o-Methoxyphenyl)-1-piperazinyl]propylamino]-1,3-dimethyluracil
NCGC00016066-02
AB00053328_10
NCGC00016066-10
AKOS015896920
NCGC00178336-01
BPBio1_000826
Prestwick3_000905
C20H29N5O3
SPBio_002949
CS-0009600
Urapidil (JP17/INN)
VZ34075
Tocris-1772
Ebrantil
2,3H)-Pyrimidinedione, 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-
HY-B0716
5-25-15-00402 (Beilstein Handbook Reference)
KBio3_002534
6-({3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl}amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione
LS-158663
6-[[3-[4-(o-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyluracil
NCGC00016066-05
AB1009497
NCGC00025290-01
AX8156200
NSC-310405
BRD-K73196317-003-07-2
RAAV2-TNFR:Fc
CC-35548
Spectrum2_001172
D0K0VO
urapidil(jan)
UNII-A78GF17HJS
DivK1c_006779
Eupressyl
2,4(1H,3H)-Pyrimidinedione, 6-((3-(4-(2-methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl- (9CI)
K-7882
6-((3-(4-(o-Methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyluracil
KS-000016PV
6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione
MolPort-004-964-587
A822334
NCGC00016066-08
AC1Q6CKO
NCGC00025290-04
BCP0726000257
Prestwick1_000905
BSPBio_003034
SMR001831470
Spectrum5_001611
Uracil,3-dimethyl-6-[3-[4-(o-methoxyphenyl)-1-piperazinyl]proppylamino]-
Urapidilum [INN-Latin]
TgAAC-94
DSSTox_RID_76154
H964
34661-75-1
KBio2_004408
6-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propylamino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione
Lopac-U-100
6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
NCGC00016066-03
AB00053328_11
NCGC00016066-11
AN-6319
NCGC00178336-02
BRD-K73196317-001-02-7
propylamino)-1,3-dimethylpyrimidine-
CAS-34661-75-1
SpecPlus_000683
CTK4H2778
Urapidil [BAN:INN:JAN]
W-106718
Tox21_110298
D0M8BE
Ebrantil (TN)
2,4(1H,3H)-dione
I07-0038
6-((3-(4- (2-methoxyphenyl)-1-piperazinyl)propyl)amino)- 1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
KBioGR_000925
6-[3-[4-(2-methoxyphenyl)-1-piperazinyl]propylamino]-1,3-dimethylpyrimidine-2,4-dione
Mediatensyl
661U751
NCGC00016066-06
AC-8246
NCGC00025290-02
B-66256
NSC310405
BRN 0725782
SBI-0051232.P003
CCG-40329
Spectrum3_001557
URACIL, 1,3-DIMETHYL-6-(3-(4-(o-METHOXYPHENYL)-1-PIPERAZINYL)PROPPYLAMINO)-
Urapidil,(S)
DSSTox_CID_1425
FT-0639207
2,4(1H,3H)-Pyrimidinedione, 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-
KBio1_001723
6-((3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl)amino)-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione #
KS-5208
6-[3-[4-(2-Methoxyphenyl)piperazinyl]propylamino]-1,3-dimethyluracil
NCGC00016066-01
AAV-huTNFR:Fc
NCGC00016066-09
AK163085
NCGC00025290-05
BCPP000025
Prestwick2_000905
C-21481
SPBio_001183
CHEMBL279229
Spectrum_001360
Uraprene
TgAAV-TNFR:Fc
DTXSID9021425
1,3-dimethyl-6-[(3-{4-[2-(methyloxy)phenyl]piperazin-1-yl}propyl)amino]pyrimidine-2,4(1H,3H)-dione
HMS1922E11
4CA-1304
KBio2_006976
6-(3-(4-(o-Methoxyphenyl)-1-piperazinyl)propylamino)-1,3-dimethyluracil
Lopac0_001265
6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyluracil
NCGC00016066-04
AB00514699
NCGC00016066-16
API0004555
NSC 310405
BRD-K73196317-003-03-1
RAAV-TNF, Targeted Genetics
CAS-64887-14-5
SPECTRUM1503100
D01333